Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
Ontology highlight
ABSTRACT: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
PROVIDER: PRJNA752351 | ENA |
REPOSITORIES: ENA
ACCESS DATA